Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes

Clinics in Dermatology

Volumn 25, Issue 6, 2007, Pages 581-588

  Albanesi, Cristina ^a   De Pità, Ornella ^a   Girolomoni, Giampiero ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; INFLAMMATION; KERATINOCYTE; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; SKIN CELL; T LYMPHOCYTE ACTIVATION;

ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; EPIDERMIS; FIBROBLASTS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; KERATINOCYTES; LYMPHOCYTE ACTIVATION; PSORIASIS; T-LYMPHOCYTES;

EID: 36048944693     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2007.08.013     Document Type: Review

References (75)

1. Bos J.D., de Rie M.A., Teunissen M.B.M., et al. Psoriasis: dysregulation of innate immunity. Br J Dermatol 152 (2005) 1098-1107
2. Gisondi P., Gubinelli E., Cocuroccia B., et al. Targeting tumor necrosis factor-alpha in the therapy of psoriasis. Curr Drug Targets Inflamm Allergy 3 (2004) 175-183
3. Wrone-Smith T., and Nickoloff B.J. Dermal injection of immunocytes induces psoriasis. J Clin Invest 98 (1996) 1878-1887
4. Sano S., Chan K.S., Carbajal S., et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11 (2005) 43-49
5. Pasparakis M., Courtois G., Hafner M., et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417 (2002) 861-866
6. Zenz R., Eferl R., Kenner L., et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437 (2005) 369-375
7. Austin L.M., Ozawa M., Kikuchi T., et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113 (1999) 752-759
8. Lee E., Trepicchio W.L., Oestreicher J.L., et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199 (2004) 125-130
9. Trembath R.C., Clough R.L., Rosbotham J.L., et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 6 (1997) 813-820
10. Gudmundsdottir A.S., Sigmundsdottir H., Sigurgeirsson B., et al. Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis?. Clin Exp Immunol 117 (1999) 580-586
11. Jones D.A., Yawalkar N., Suh Ki.-Y., et al. Identification of autoantigens in psoriatic plaques using expression cloning. J Invest Dermatol 123 (2004) 93-100
12. Majewski S., and Jablonska S. Possible involvement of epidermodysplasia verruciformis human papillomaviruses in the immunopathogenesis of psoriasis: a proposed hypothesis. Exp Dermatol 12 (2003) 721-728
13. Albanesi C., Scarponi C., Giustizieri M.L., et al. Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 4 (2005) 329-334
14. Ottaviani C., Nasorri F., Bedini C., et al. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 36 (2006) 118-128
15. Prinz J.C. Psoriasis vulgaris-a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Clin Exp Dermatol 26 (2001) 326-332
16. Bata-Csorgo Z., Hammerberg C., Voorhees J.J., et al. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 178 (1993) 1271-1281
17. McKay I.A., and Leigh I.M. Altered keratinocyte growth and differentiation in psoriasis. Clin Dermatol 13 (1995) 105-114
18. Iizuka H., Takahashi H., Honma M., et al. Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J Dermatol 31 (2004) 271-276
19. Nickoloff B.J., Ben-Neriah Y., and Pikarsky E. Inflammation and cancer: is the link as simple as we think?. J Invest Dermatol 124 (2005) x-xiv
20. Piepkorn M., Pittelkow M.R., and Cook P.W. Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. J Invest Dermatol 111 (1998) 715-721
21. Glick A.B., Kulkarni A.B., Tennenbaum T., et al. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci U S A 90 (1993) 6076-6080
22. Guo L., Yu Q.C., and Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J 12 (1993) 973-986
23. Vassar R., and Fuchs E. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev 5 (1991) 714-727
24. Cook P.W., Piepkorn M., Clegg C.H., et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Invest 100 (1997) 2286-2294
25. Hines M.D., and Allen-Hoffmann B.L. Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes. J Biol Chem 271 (1996) 6245-6251
26. Bhagavathula N., Nerusu K.C., Fisher G.J., et al. Amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. Am J Pathol 166 (2005) 1009-1016
27. Kane C.J., Knapp A.M., Mansbridge J.N., et al. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol 144 (1990) 144-150
28. Doi H., Shibata M.A., Kiyokane K., et al. Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris. J Dermatol Sci 33 (2003) 7-16
29. Li A.G., Wang D., Feng X.H., et al. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J 23 (2004) 1770-1781
30. Grossman R.M., Krueger J., Yourish D., et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci 86 (1989) 6367-6371
31. Otkjaer K., Kragballe K., Funding A.T., et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol 153 (2005) 911-918
32. Koks S., Kingo K., Ratsep R., et al. Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes Immun 5 (2004) 662-667
33. Bata-Csorgo Z., Hammerberg C., Voorhees J.J., et al. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 95 (1995) 317-327
34. Fierlbeck G., Rassner G., and Müller C. Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch Dermatol 126 (1990) 351-355
35. Jackson M., Howie S.E., Weller R., et al. Psoriatic keratinocytes show reduced IRF-1 and STAT-1α activation in response to gamma-IFN. FASEB J 13 (1999) 495-502
36. Chen S.H., Arany I., Apisarnthanarax N., et al. Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha (2)-glycoprotein and cathepsin D. FASEB J 14 (2000) 565-571
37. Scheynius A., Fransson J., Johansson C., et al. Expression of interferon-gamma receptors in normal and psoriatic skin. J Invest Dermatol 98 (1992) 255-258
38. Suomela S., Elomaa O., Asumalahti K., et al. HCR, a candidate gene for psoriasis, is expressed differently in psoriasis and other hyperproliferative skin disorders and is downregulated by interferon-gamma in keratinocytes. J Invest Dermatol 121 (2003) 1360-1364
39. Albanesi C., Cavani A., and Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 162 (1999) 494-502
40. Schön M.P., and Ruzicka T. Psoriasis: the plot thickens.... Nat Immunol 2 (2001) 91
41. Nickoloff B.J., and Turka L.A. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immuno Today 15 (1994) 464-469
42. Gillitzer R., Wolff K., Tong D., et al. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101 (1993) 127-131
43. Gottlieb A.B., Luster A.D., Posnett D.N., et al. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 168 (1998) 941-948
44. Dieu-Nosjan M.C., Massacrier C., Homey B., et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 192 (2000) 705-718
45. Homey B., Wang W., Soto H., et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164 (2000) 3465-3470
46. Vanbervliet B., Homey B., Durand I., et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur J Immunol 32 (2002) 231-242
47. Homey B., Alenius H., Müller A., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8 (2002) 157-165
48. Hudak S., Hagen M., Liu Y., et al. Immune surveillance and effector functions of CCR10(+) skin homing T cells. J Immunol 169 (2002) 1189-1196
49. Nomura I., Gao B., Boguniewicz, et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112 (2003) 1195-1202
50. Giustizieri M.L., Albanesi C., Scarponi C., et al. Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo. Am J Pathol 161 (2002) 1409-1418
51. Bruch-Gerharz D., Schnorr O., Suschek C., et al. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol 162 (2003) 203-211
52. Namazi M.R. Explaining decreased nitric oxide production in psoriatic lesions: arginase 1 overexpression versus calcitonin gene-related peptide. Am J Pathol 163 (2003) 2642-2643
53. Asadullah K., Sabat R., Friedrich M., et al. Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy 3 (2004) 185-192
54. Mrowietz U., and Asadullah K. Dimethylfumarate for psoriasis: more than a dietary curiosity. Trends Mol Med 11 (2005) 43-48
55. Reich K., Garbe C., Blaschke V., et al. Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, down-regulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation. J Invest Dermatol 116 (2001) 319-329
56. Stoof T.J., Flier J., Sampat S., et al. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br J Dermatol 144 (2001) 1114-1120
57. Kupper T.S., and Groves R.W. The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 105 (1995) 62S-66S
58. Groves R.W., Sherman L., Mizutani H., et al. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis. Am J Pathol 145 (1994) 1048-1056
59. Groves R.W., Rauschmayr T., Nakamura K., et al. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest 98 (1996) 336-344
60. Rückert R., Asadullah K., Seifert M., et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?. J Immunol 165 (2000) 2240-2250
61. Kawase Y., Hoshino T., Yokota K., et al. Exacerbated and prolonged allergic and non-allergic inflammatory cutaneous reaction in mice with targeted interleukin-18 expression in the skin. J Invest Dermatol 121 (2003) 502-509
62. Detmar M., Brown L.F., Claffey K.P., et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180 (1994) 1141-1146
63. Werner S., and Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol 11 (2001) 143-146
64. Maas-Szabowski N., Shimotoyodome A., and Fusenig N.E. Keratinocyte growth regulation in fibroblast coculture via a double paracrine mechanism. J Cell Sci 112 (1999) 1843-1853
65. Blomme E.A.G., Sugimoto Y., Lin Y.C., et al. Parathyroid hormone-related protein is a positive regulator of keratinocyte growth factor expression by normal dermal fibroblasts. Mol Cell Endocrinol 152 (1999) 189-197
66. Suzuki K., Yamanishi K., Mori O., et al. Defective terminal differentiation and hypoplasia of the epidermis in mice lacking the Fgf10 gene. FEBS Lett 481 (2000) 53-56
67. Lowe P.M., Lee M.L., Jackson C.J., et al. The endothelium in psoriasis. Br J Dermatol 132 (1995) 497-505
68. Lebwohl M. Psoriasis. Lancet 361 (2003) 1197-1204
69. Girolomoni G., Pastore S., Cavani A., et al. The role of chemokines in inflammatory skin diseases. Ernst Schering Res Found Workshop (2004) 191-225
70. D'Ambrosio D., Albanesi C., Lang R., et al. Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion. J Immunol. 169 (2002) 2303-2312
71. Fitzhugh D.J., Naik S., Caughman S.W., et al. C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro. J Immunol 165 (2000) 6677-6681
72. Fraticelli P., Sironi M., Bianchi G., et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107 (2001) 1173-1181
73. McKenzie R.C., and Sabin E. Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 12 (2003) 337-345
74. Simon J.C., and Darragh J. Signaling downstream of p38 psoriasis. J Invest Dermatol 126 (2006) 1689-1691
75. Federici M., Giustizieri M.L., Scarponi C., et al. Impaired IFN-γ-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J Immunol. 169 (2002) 434-442